Value of serum and follicular fluid cytokine profile in the prediction of moderate to severe ovarian hyperstimulation syndrome

被引:50
作者
Chen, CD [1 ]
Chen, HF [1 ]
Lu, HF [1 ]
Chen, SU [1 ]
Ho, HN [1 ]
Yang, YS [1 ]
机构
[1] Natl Taiwan Univ, Coll Med & Hosp, Dept Obstet & Gynecol, Taipei 10764, Taiwan
关键词
cytokine; follicular fluid; ovarian hyperstimulation syndrome; prediction; vascular endothelial growth factor;
D O I
10.1093/humrep/15.5.1037
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The aim of this study was to examine the role of serum and follicular fluid pro-inflammatory cytokines and vascular endothelial growth factor (VEGF) in the prediction of ovarian hyperstimulation syndrome (OHSS). A total of 156 consecutive women undergoing in-vitro fertilization were recruited. The study group comprised 12 women who subsequently developed moderate(n = 7) or severe (n = 5) OHSS. The two control groups were comprised of a randomized selection of 12 high-risk and 12 low-risk women in whom OHSS did not develop. Serum was collected on days of human chorionic gonadotrophin, oocyte retrieval, and embryo transfer. Serum and follicular fluid concentrations of interleukin (IL)-6, IL-8, tumour necrosis factor-alpha (TNF-alpha), and VEGF were measured. Follicular fluid IL-6 concentrations at the time of oocyte retrieval and serum IL-8 concentrations at the time of embryo transfer were significantly higher in the OHSS compared to the two control groups (P = 0.026 and P = 0.017 respectively). Serum concentrations of TNF-alpha and VEGF showed no statistically significant difference between the OHSS group and the controls at any studied time point. This study suggests that follicular fluid IL-6 concentrations at the time of oocyte retrieval and serum IL-8 concentrations on the day of embryo transfer may serve as early predictors for this syndrome.
引用
收藏
页码:1037 / 1042
页数:6
相关论文
共 50 条
  • [31] NEW INSIGHTS IN PREDICTION OF OVARIAN HYPERSTIMULATION SYNDROME
    Kasum, Miro
    Oreskovic, Slavko
    ACTA CLINICA CROATICA, 2011, 50 (02) : 281 - 288
  • [32] INCIDENCE OF SEVERE OVARIAN HYPERSTIMULATION SYNDROME WITH EXTREMELY ELEVATED SERUM ESTROGEN-LEVELS
    JAFFE, SB
    JAFFE, LH
    JEWELEWICZ, R
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1993, 35 (04) : 222 - 227
  • [33] Prognostic role of follicular fluid tumor necrosis factor alpha in the risk of early ovarian hyperstimulation syndrome
    Miaad Jabbar Alhilali
    Abbas Parham
    Armin Attaranzadeh
    Malihe Amirian
    Mohammad Azizzadeh
    BMC Pregnancy and Childbirth, 20
  • [34] Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome
    Chen, CD
    Wu, MY
    Chen, HF
    Chen, SU
    Ho, HN
    Yang, YS
    FERTILITY AND STERILITY, 1999, 72 (02) : 286 - 292
  • [35] Catastrophic antiphospholipid syndrome related to severe ovarian hyperstimulation
    V. Giner
    M. R. Oltra
    M. J. Esteban
    M. J. García-Fuster
    A Salvador
    J. Núñez
    J. Redón
    Clinical Rheumatology, 2007, 26 : 991 - 993
  • [36] Plasma immunoglobulins in patients with severe ovarian hyperstimulation syndrome
    Abramov, Y
    Naparstek, Y
    Elchalal, U
    Lewin, A
    Schechter, E
    Schenker, JG
    FERTILITY AND STERILITY, 1999, 71 (01) : 102 - 105
  • [37] LUTEAL PHASE SUPPORT AND SEVERE OVARIAN HYPERSTIMULATION SYNDROME
    MCCLURE, N
    LEYA, J
    RADWANSKA, E
    RAWLINS, R
    HANING, RV
    HUMAN REPRODUCTION, 1992, 7 (06) : 758 - 764
  • [38] Comparison of follicular fluid and serum levels of Inhibin A and Inhibin B with calculated indices used as predictive markers of ovarian hyperstimulation syndrome in IVF patients
    Jiri Moos
    Karel Rezabek
    Vanda Filova
    Martina Moosova
    Jana Pavelkova
    Jana Peknicova
    Reproductive Biology and Endocrinology, 7
  • [39] Can we eliminate severe ovarian hyperstimulation syndrome?
    Orvieto, R
    HUMAN REPRODUCTION, 2005, 20 (02) : 320 - 322
  • [40] Catastrophic antiphospholipid syndrome related to severe ovarian hyperstimulation
    Giner, V.
    Oltra, M. R.
    Esteban, M. J.
    Garcia-Fuster, M. J.
    Salvador, A.
    Nunez, J.
    Redon, J.
    CLINICAL RHEUMATOLOGY, 2007, 26 (06) : 991 - 993